how safe is hers semaglutide Wegovy® Pill and Wegovy® Pen Now Available with Hims & Hims & Hers Expands Personalized

Complete system balance and support

Find out more what each individual course of study offers through the locations below

The results from clinical trials are hard to ignore

Key limitations of current evidence include: Relatively short follow-up periods (typically 35 years) in randomised trials, whereas pancreatic cancer may take years to develop Potential for detection bias, as patients on GLP-1 therapy may undergo more frequent medical monitoring Difficulty accounting for all confounding factors in observational studies Despite these limitations, the weight of current evidence does not support a causal link between GLP-1 receptor agonist use and pancreatic cancer development